γδ T-cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B-cells impairment

Immunology Letters

Volumn 68, Issue 2-3, 1999, Pages 289-293

  Kretowski, Adam ^a   Mysliwiec, Janusz ^a   Szelachowska, Malgorzata ^a   Turowski, Dariusz ^a   Wysocka, Jolanta ^a   Kowalska, Irina ^a   Kinalska, Ida ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

T lymphocytes; Prediction; Type 1 diabetes mellitus

Indexed keywords

T LYMPHOCYTE RECEPTOR; AUTOANTIBODY; BIOLOGICAL MARKER; INSULIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AUTOIMMUNITY; CELL FUNCTION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; ARTICLE; BLOOD; CHILD; FORECASTING; GENETICS; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; LYMPHOCYTE COUNT; PANCREAS ISLET; SECRETION;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FORECASTING; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; ISLETS OF LANGERHANS; LYMPHOCYTE COUNT; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 0033137349     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(99)00066-8     Document Type: Conference Paper

References (26)

1. Bingley P.J, Christie M.R., Bonifacio E., Bonfani R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 43:1994;1304-1310.
2. Knip M., Karjalajnen J., Akerblom H.K. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. Diabetes Care. 21:1998;1670-1673.
3. Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Botazzo G.F., Gale E.A.M. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 46:1997;1701-1710.
4. O'Garra A., Steinman L., Gijbels K. CD4+ subsets in autoimmunity. Curr. Opin. Immun. 9:1997;872-883.
5. Schloot N.C., Willemen S., Duinkerken G., de Vries R.R.P., Roep B.O. Cloned T cells from a recent onset IDDM patients reactive with insulin B-chain. J. Autoimmun. 11:1998;169-175.
6. Naquet G.G., Ellis J., Tibensky D., Kenshole A., Singh B., Hodges R., Delovitch T.L. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol. 140:1988;2560-2578.
7. Martin S., Heidenthal E., Schulte B., Rothe H., Kolb H. Soluble forms of intracellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia. 41:1998;1298-1303.
8. Kretowski A., Szelachowska M., Pietruczuk M., Kinalska I. CD23 antigen expression on B lymphocytes and soluble CD23 levels in peripheral blood of high-risk type 1 diabetes subjects. Scand. J. Immunol. 49:1999;78-81.
9. Hussain M.J., Maher J., Warnock T., Vats A., Peakman M., Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia. 41:1998;343-349.
10. Szelachowska M., Kretowski A., Kinalska I. Increased in vitro interleukin 12 production by peripheral blood in high risk IDDM first degree relatives. Horm. Metab. Res. 29:1997;168-171.
11. Hayday A., Geng L. γδ Cells regulate autoimmunity. Curr. Opin. Immunol. 9:1997;884-889.
12. Groh V., Porcelli S., Fabbi M. Human lymphocytes bearing T cell receptor gamma/delta are phenotipically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 169:1998;1277-1294.
13. De Libero G. Sentinel function of broadly reactive human γδ T cells. Immunol. Today. 18:1997;22-26.
14. Ke Y., Pearce K., Lake J.P., Ziegler H.K., Kapp J.A. T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158:1997;3610-3618.
15. Stinissen P., Vandevyver C., Medaer R., Vandegaer L., Nies J., Tuyls L., Hafler D.A., Raus J., Zhang J. Increased frequency of γδ T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity and T cell receptor V gene rearrangements. J. Immunol. 154:1995;4883-4894.
16. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:1996;2167-2174.
17. P.J. Bingley, for the ICARUS group. Interaction of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives. Diabetes 45 (1996) 1720-1728.
18. Roura-Mir C., Vargas A.F., Tolosa E., Obiols G., Foz M., Jaraquemada D., Pujol-Borrell R. T lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes. Clin. Exp. Immunol. 92:1993;288-295.
19. Keystone E.C., Rittershaus C., Wood N., Snow K.M., Flatow J., Purvis J.C., Poplonski L., Kung P.C. Elevation of a γδ T cell subset in peripheral and synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 84:1991;78-82.
20. Olive C., Gatenby P.A., Serjeantson S.W. Restricted junctional diversity of T cell receptor δ gene rearrangements expressed in systemic lupus erythematosus (SLE) patients. Clin. Exp. Immunol. 97:1994;430-438.
21. Rajagoplan S., Zordan T., Tsokos G., Datta S.K. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-CD8- T helper cell lines that express the γδ T-cell antigen receptor. Proc. Natl. Acad. Sci. 87:1990;7020-7024.
22. Lang F.P., Pollock B.H., Riley W.J., Maclaren N.K., Barrett D.J. The temporal association between γδ T cells and the natural history of insulin-dependent diabetes. J. Autoimmun. 1:1993;107-119.
23. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. Prediction of type 1 diabetes in first degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes. 45:1996;926-933.
24. A. Kretowski, J. Myśliwiec, M. Szelachowska, M. Kinalski, I. Kinalska. Insulin increases in vitro production of Th2 profile cytokines in peripheral blood cultures in high risk of diabetes type 1 subjects and patients with newly diagnosed IDDM. Horm. Metab. Res. 1999 (in press).
25. Catalfamo M., Roura-Mir C., Sospedra M., Aparicio P., Costagliola S., Ludgate M., Pujol-Borrell R., Jaraquemada D. Self-reactive cytotoxic γδ T lymphocytes in Graves' disease specifically recognise thyroid epithelial cells. J. Immunol. 156:1996;804-811.
26. Gladstone P., Nepom G.T. The prevention of IDDM. Injecting insulin into the cytokine network. Diabetes. 44:1995;858-861.